| GC31254-5mg |
|
56699-31-1 |
Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate)
|
0 |
C25H38O4 |
|
|
|
| GC31254-1mg |
|
56699-31-1 |
Androst-4-ene-3,17-diol, dipropanoate, (3β,17β)- (Androst-4-ene-3β,17β-diol, dipropionate)
|
0 |
C25H38O4 |
|
|
|
| GC31253-100mg |
|
373-49-9 |
|
0 |
C16H30O2 |
|
|
|
| GC31252-20mg |
|
124991-40-8 |
|
0 |
C17H19ClO4 |
|
|
|
| GC31252-10mg |
|
124991-40-8 |
|
0 |
C17H19ClO4 |
|
|
|
| GC31252-5mg |
|
124991-40-8 |
|
0 |
C17H19ClO4 |
|
|
|
| GC31252-1mg |
|
124991-40-8 |
|
0 |
C17H19ClO4 |
|
|
|
| GC31250-25mg |
|
77514-44-4 |
Opioid receptor modulator 1
|
0 |
C18H23NO2 |
|
|
|
| GC31250-10mg |
|
77514-44-4 |
Opioid receptor modulator 1
|
0 |
C18H23NO2 |
|
|
|
| GC31250-5mg |
|
77514-44-4 |
Opioid receptor modulator 1
|
0 |
C18H23NO2 |
|
|
|
| GC31249-10mg |
|
389572-87-6 |
2: PN: US20040072744 SEQID: 2 claimed protein
|
0 |
C43H67N13O17S |
|
|
|
| GC31249-5mg |
|
389572-87-6 |
2: PN: US20040072744 SEQID: 2 claimed protein
|
0 |
C43H67N13O17S |
|
|
|
| GC31249-1mg |
|
389572-87-6 |
2: PN: US20040072744 SEQID: 2 claimed protein
|
0 |
C43H67N13O17S |
|
|
|
| GC31248-20mg |
|
610300-00-0 |
β-Amino Acid Imagabalin Hydrochloride (PD-0332334)
|
0 |
C9H20ClNO2 |
|
|
|
| GC31248-10mg |
|
610300-00-0 |
β-Amino Acid Imagabalin Hydrochloride (PD-0332334)
|
0 |
C9H20ClNO2 |
|
|
|
| GC31248-5mg |
|
610300-00-0 |
β-Amino Acid Imagabalin Hydrochloride (PD-0332334)
|
0 |
C9H20ClNO2 |
|
|
|
| GC31248-1mg |
|
610300-00-0 |
β-Amino Acid Imagabalin Hydrochloride (PD-0332334)
|
0 |
C9H20ClNO2 |
|
|
|
| GC31247-20mg |
|
128199-93-9 |
|
0 |
C18H21N3O |
|
|
|
| GC31247-10mg |
|
128199-93-9 |
|
0 |
C18H21N3O |
|
|
|
| GC31247-5mg |
|
128199-93-9 |
|
0 |
C18H21N3O |
|
|
|
